Inflammation in Experimental Models of α‐Synucleinopathies
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Neuroinflammation has long been associated with central nervous system pathology in α‐synucleinopathy disorders including Parkinson's disease and multiple system atrophy. In the past decade, research‐focused efforts in preclinical and experimental models have rallied around this idea, and considerable effort has been made to delineate critical neuroinflammatory processes. In this article, we discuss challenges in preclinical research, notably the use of animal models to recapitulate and dissect disease phenotypes as well as the need for more sensitive, reliable radiotracers to detect on‐target efficacy of immunomodulatory treatments in both human Parkinson's disease as well as preclinical models. © 2020 International Parkinson and Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kim, S., Kwon, S.-H., Kam, T.-I., Panicker, N., Karuppagounder, S. S., Lee, S., Lee, J. H., Kim, W. R., Kook, M., Foss, C. A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.035 · Cited by 1,397
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344 · cited 1×
“Based on this idea, one focus of current research is maintaining the balance between neuroinflammation and neurorepair and/or tissue healing in neurodegenerative disease models.(88,89) Indeed, there is evidence in animal models of PD(90) for an imbalance between disease driving neuroinflammation and proresolving proce…”
BackgroundIn vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
Yun, S. P., Kam, T.-I., Panicker, N., Kim, S., Oh, Y., Park, J.-S., Kwon, S.-H., Park, Y. J., Karuppagounder, S. S., Park, H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0051-5 · Cited by 1,123 · cited 1×
“To date, infiltration of peripheral immune cells, specifically natural killer cells, have also been reported in response to α-synuclein PFFs(79) as well as robust A1 astrocyte activation.(80) It is important to note that inflammatory mechanisms in the PFF model have not been extensively characterized or shown to be cr…”
BackgroundMogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
Self-citationKim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856
Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801
Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia
Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N. (2013) · Glia · doi:10.1002/glia.22437 · Cited by 697
Cited by
Szego, E. M., Malz, L., Bernhardt, N., Rösen-Wolff, A., Falkenburger, B. H., & Luksch, H. (2022) · eLife · doi:10.7554/elife.81943 · Cited by 94
“Inflammation contributes significantly to the pathogenesis of neurodegenerative diseases, including Parkinson’s disease (PD) (Harms et al., 2021; Hirsch and Standaert, 2021).”
BackgroundInfluentialInflammation in multiple system atrophy
Leńska-Mieciek, M., Madetko-Alster, N., Alster, P., Królicki, L., Fiszer, U., & Koziorowski, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1214677 · Cited by 45
Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
Lai, T. T., Kim, Y. J., Ma, H.-I., & Kim, Y. E. (2022) · Journal of Movement Disorders · doi:10.14802/jmd.21078 · Cited by 32
Lai, T. T., Kim, Y. J., Nguyen, P. T., Koh, Y. H., Nguyen, T. T., Ma, H.-I., & Kim, Y. E. (2021) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2021.715190 · Cited by 24
Alpha synuclein overexpression can drive microbiome dysbiosis in mice
Sampson, T. R., Wallen, Z. D., Won, W.-J., Standaert, D. G., Payami, H., & Harms, A. S. (2025) · Scientific Reports · doi:10.1038/s41598-024-82139-7 · Cited by 11
Self-citation
Metadata
- Authors
- Harms, A. S., Kordower, J. H., Sette, A., Lindestam Arlehamn, C. S., Sulzer, D., & Mach, R. H.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2020-10-03
- Volume
- 36
- Issue
- 1
- Pages
- 37-49
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W3090881569
- Cited by
- 29
- References
- 44
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inflammation in Experimental Models of α‐Synucleinopathies. https://app.cochat.ai/papers/10.1002/mds.28264
- The paper
- Harms, A. S., Kordower, J. H., Sette, A., Lindestam Arlehamn, C. S., Sulzer, D., & Mach, R. H. (2021). Inflammation in Experimental Models of α‐Synucleinopathies. Movement Disorders. https://doi.org/10.1002/mds.28264
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.